The U.S. Food and Drug Administration has approved the use of Novartis’ drug to reduce excess protein in the urine of patients with a type of kidney disease, the health regulator’s website showed on Wednesday.
Launched this past Monday, Neon, an IPG Health company, and Artists for Action unveiled a new campaign called ‘Not So Lucky’ to draw attention to the epidemic of gun violence in America’s schools. Simply put, the campaign’s target audience is “everyone who lives in the United States and cares about the safety of our kids in our schools,” Jesse Kates, managing director/creative lead at Neon, an IPG Health company, told Med Ad News.
CMI Media Group has signed on as sponsors in support of Blackweek, a new economic forum and marketing conference created to disrupt the current conversation around diversity, equity, and inclusion (DE&I). Launching this October 15-18 in New York City, Blackweek empowers diverse and non-diverse professionals with information, ideas, and insights to find common ground in their mutual pursuit of the immense economic impact that lies within diverse communities and their respective influence on global commerce.
A review of the latest leadership moves in the pharma industry.
A day after Eli Lilly’s obesity and weight-loss therapies were removed from the regulator’s database, Novo Nordisk also made strides in boosting the supply of all but one of semaglutide’s shortages.
Lobbying groups and individuals connected with the industry are supporting candidates from both parties, with a particular focus on the future of the 340B discount program and pharmacy benefit managers.